secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0000950170-24-061330
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE receives Nasdaq delisting notice for negative equity of -$1.93M
-----------------------------------------------------------------------

- Nasdaq notified BIOLASE on May 14, 2024 that stockholders' equity of ($1.93M) fails minimum $2.5M requirement.
- This is an additional basis for delisting and will be considered by the Nasdaq Hearings Panel.
- Company has requested a hearing before the Panel, scheduled for June 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000095017024061330/0000950170-24-061330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000095017024061330/biol-20240517.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-061330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer